Title:
3C-LIKE PROTEASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/227117
Kind Code:
A1
Abstract:
Provided in the present invention is a 3C-like protease inhibitor as shown in formula (I), or a pharmaceutically acceptable salt, isotopic variant, tautomer, stereoisomer, prodrug, polymorph, hydrate or solvate thereof. Also provided in the present invention are a preparation method of the compound, a pharmaceutical composition containing the compound, and an effect of the compound in treating or preventing diseases caused by virus infection.
Inventors:
ZHANG HONGBO (CN)
YANG QI (CN)
ZHANG WEI (CN)
SUN JING (CN)
SHI LEI (CN)
DING KANG (CN)
WANG HUTING (CN)
XU QINGBO (CN)
HUANG BO (CN)
ZHAO JINCUN (CN)
CHEN XINWEN (CN)
PENG WEI (CN)
YANG QI (CN)
ZHANG WEI (CN)
SUN JING (CN)
SHI LEI (CN)
DING KANG (CN)
WANG HUTING (CN)
XU QINGBO (CN)
HUANG BO (CN)
ZHAO JINCUN (CN)
CHEN XINWEN (CN)
PENG WEI (CN)
Application Number:
PCT/CN2023/096587
Publication Date:
November 30, 2023
Filing Date:
May 26, 2023
Export Citation:
Assignee:
GUANGZHOU NAT LABORATORY (CN)
BEIJING STONEWISE TECH CO LTD (CN)
BEIJING STONEWISE TECH CO LTD (CN)
International Classes:
C07D401/04; A61K31/53; A61P31/14; C07D401/14; C07D403/14; C07D405/14; C07D407/14; C07D417/14; C07D487/04
Domestic Patent References:
| WO2013089212A1 | 2013-06-20 |
Foreign References:
| CN115038696A | 2022-09-09 | |||
| CN102395571A | 2012-03-28 |
Attorney, Agent or Firm:
LIU , SHEN & ASSOCIATES (CN)
Download PDF: